A Phase II Randomized-double Blinded Placebo Controlled Window of Opportunity Trial Comparing Conjugated Estrogens/Bazedoxifene to Placebo in Women Undergoing Surgical Therapy for Ductal Carcinoma in Situ (DCIS)
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 03 Jan 2017 Status changed from not yet recruiting to recruiting.
- 01 Sep 2016 Planned initiation date changed from 1 Mar 2016 to 1 Sep 2016.